[시장보고서]습진 : 시장 인사이트, 역학 및 시장 예측(-2034년)

습진 : 시장 인사이트, 역학 및 시장 예측(-2034년)

Eczema - Market Insight, Epidemiology, and Market Forecast - 2034

상품코드 : 1506769

리서치사 : DelveInsight

발행일 : On Demand Report

페이지 정보 : 영문 200 Pages

라이선스 & 가격 (부가세 별도)

US $ 7,950

￦ 11,417,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,925

￦ 17,126,000

PDF (2-3 User License)

PDF 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 15,900

￦ 22,835,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 23,850

￦ 34,253,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

앞으로 몇 년동안 습진(피부염) 시장은 이 질환에 대한 인식이 높아지고 전 세계 의료비 지출이 증가함에 따라 변화할 것으로 보입니다.

기업과 연구기관들은 습진(피부염) 연구개발에 영향을 미칠 수 있는 과제를 평가하고 기회를 모색하기 위해 노력하고 있습니다. 개발 중인 치료법은 질환을 치료/개선하기 위한 새로운 접근법에 초점을 맞추었습니다. 주요 기업들이 습진(피부염) 치료제 개발에 참여하고 있습니다. 새로운 치료법의 등장은 습진(피부염) 시장에 큰 영향을 미칠 것으로 예상됩니다.

이 보고서는 주요 7개국의 습진(피부염) 시장을 조사했으며, 시장 개요와 함께 역학, 환자 동향, 새로운 치료법, 2034년까지 시장 규모 예측, 미충족 의료 수요 등의 정보를 제공합니다.

영문목차

DelveInsight's "Eczema - Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Eczema, historical and forecasted epidemiology as well as the Eczema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Eczema market report provides current treatment practices, emerging drugs, Eczema market share of the individual therapies, current and forecasted Eczema market size from 2020 to 2034 segmented by seven major markets. The Report also covers current Eczema treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered:

The United States
EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Japan

Study Period: 2020-2034

Eczema Disease Understanding and Treatment Algorithm

The DelveInsight Eczema market report gives a thorough understanding of the Eczema by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Eczema.

Treatment

It covers the details of conventional and current medical therapies available in the Eczema market for the treatment of the condition. It also provides Eczema treatment algorithms and guidelines in the United States, Europe, and Japan.

Eczema Epidemiology

The Eczema epidemiology division provide insights about historical and current Eczema patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Eczema epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.

Country Wise-Eczema Epidemiology

The epidemiology segment also provides the Eczema epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Eczema Drug Chapters

Drug chapter segment of the Eczema report encloses the detailed analysis of Eczema marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Eczema clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Eczema treatment.

Eczema Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Eczema treatment.

Eczema Market Outlook

The Eczema market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Eczema market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Eczema market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Eczema market in 7MM is expected to change in the study period 2020-2034.

Key Findings

This section includes a glimpse of the Eczema market in 7MM.

The United States Market Outlook

This section provides the total Eczema market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Eczema market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Eczema market size and market size by therapies in Japan is also mentioned.

Eczema Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Eczema market or expected to get launched in the market during the study period 2020-2034. The analysis covers Eczema market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Eczema Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Eczema key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Eczema emerging therapies.

Reimbursement Scenario in Eczema

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Eczema domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Eczema market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Eczema Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report:

The report covers the descriptive overview of Eczema, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
Comprehensive insight has been provided into the Eczema epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for Eczema are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of Eczema market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Eczema market

Report Highlights:

In the coming years, Eczema market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
The companies and academics are working to assess challenges and seek opportunities that could influence Eczema R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
Major players are involved in developing therapies for Eczema. Launch of emerging therapies will significantly impact the Eczema market
A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Eczema
Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Eczema Report Insights

Patient Population
Therapeutic Approaches
Eczema Pipeline Analysis
Eczema Market Size and Trends
Market Opportunities
Impact of upcoming Therapies

Eczema Report Key Strengths

11 Years Forecast
7MM Coverage
Eczema Epidemiology Segmentation
Key Cross Competition
Highly Analyzed Market
Drugs Uptake

Eczema Report Assessment

Current Treatment Practices
Unmet Needs
Pipeline Product Profiles
Market Attractiveness
Market Drivers and Barriers

Key Questions:

Market Insights:

What was the Eczema market share (%) distribution in 2020 and how it would look like in 2034?
What would be the Eczema total market size as well as market size by therapies across the 7MM during the forecast period (2024-2034)?
What are the key findings pertaining to the market across 7MM and which country will have the largest Eczema market size during the forecast period (2024-2034)?
At what CAGR, the Eczema market is expected to grow in 7MM during the forecast period (2020-2034)?
What would be the Eczema market outlook across the 7MM during the forecast period (2020-2034)?
What would be the Eczema market growth till 2032, and what will be the resultant market Size in the year 2034?
How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

What is the disease risk, burden and unmet needs of the Eczema?
What is the historical Eczema patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
What would be the forecasted patient pool of Eczema in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Eczema?
Out of all 7MM countries, which country would have the highest prevalent population of Eczema during the forecast period (2020-2034)?
At what CAGR the population is expected to grow in 7MM during the forecast period (2020-2034)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

What are the current options for the Eczema treatment, along with the approved therapy?
What are the current treatment guidelines for the treatment of Eczema in the USA, Europe, and Japan?
What are the Eczema marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
How many companies are developing therapies for the treatment of Eczema?
How many therapies are developed by each company for Eczema treatment?
How many are emerging therapies in mid-stage, and late stage of development for Eczema treatment?
What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Eczema therapies?
What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
What are the clinical studies going on for Eczema and their status?
What are the key designations that have been granted for the emerging therapies for Eczema?
What are the global historical and forecasted market of Eczema?

Reasons to buy:

The report will help in developing business strategies by understanding trends shaping and driving the Eczema market
To understand the future market competition in the Eczema market and Insightful review of the key market drivers and barriers
Organize sales and marketing efforts by identifying the best opportunities for Eczema in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
Organize sales and marketing efforts by identifying the best opportunities for Eczema market
To understand the future market competition in the Eczema market

1. Key Insights

2. Executive Summary of Eczema

3. Competitive Intelligence Analysis for Eczema

4. Eczema: Market Overview at a Glance

4.1. Eczema Total Market Share (%) Distribution in 2020
4.2. Eczema Total Market Share (%) Distribution in 2034

5. Eczema: Disease Background and Overview

5.1. Introduction
5.2. Sign and Symptoms
5.3. Pathophysiology
5.4. Risk Factors
5.5. Diagnosis

6. Patient Journey

7. Eczema Epidemiology and Patient Population

7.1. Epidemiology Key Findings
7.2. Assumptions and Rationale: 7MM
7.3. Epidemiology Scenario: 7MM
- 7.3.1. Eczema Epidemiology Scenario in the 7MM (2020-2034)
7.4. United States Epidemiology
- 7.4.1. Eczema Epidemiology Scenario in the United States (2020-2034)
7.5. EU-5 Country-wise Epidemiology
- 7.5.1. Germany Epidemiology
  - 7.5.1.1. Eczema Epidemiology Scenario in Germany (2020-2034)
- 7.5.2. France Epidemiology
  - 7.5.2.1. Eczema Epidemiology Scenario in France (2020-2034)
- 7.5.3. Italy Epidemiology
  - 7.5.3.1. Eczema Epidemiology Scenario in Italy (2020-2034)
- 7.5.4. Spain Epidemiology
  - 7.5.4.1. Eczema Epidemiology Scenario in Spain (2020-2034)
- 7.5.5. United Kingdom Epidemiology
  - 7.5.5.1. Eczema Epidemiology Scenario in the United Kingdom (2020-2034)
- 7.5.6. Japan Epidemiology
  - 7.5.6.1. Eczema Epidemiology Scenario in Japan (2020-2034)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Eczema Treatment and Management
8.2. Eczema Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Eczema Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM
11.2. Drug Name: Company Name
- 11.2.1. Product Description
- 11.2.2. Regulatory Milestones
- 11.2.3. Other Developmental Activities
- 11.2.4. Pivotal Clinical Trials
- 11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross
12.2. Drug Name: Company Name
- 12.2.1. Product Description
- 12.2.2. Other Developmental Activities
- 12.2.3. Clinical Development
- 12.2.4. Safety and Efficacy
- 12.2.5. Product Profile

List to be continued in report

13. Eczema: Seven Major Market Analysis

13.1. Key Findings
13.2. Eczema Market Size in 7MM
13.3. Eczema Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size
- 15.1.1. Eczema Total Market Size in the United States
- 15.1.2. Eczema Market Size by Therapies in the United States
15.2. EU-5 countries: Market Size and Outlook
15.3. Germany Market Size
- 15.3.1. Eczema Total Market Size in Germany
- 15.3.2. Eczema Market Size by Therapies in Germany
15.4. France Market Size
- 15.4.1. Eczema Total Market Size in France
- 15.4.2. Eczema Market Size by Therapies in France
15.5. Italy Market Size
- 15.5.1. Eczema Total Market Size in Italy
- 15.5.2. Eczema Market Size by Therapies in Italy
15.6. Spain Market Size
- 15.6.1. Eczema Total Market Size in Spain
- 15.6.2. Eczema Market Size by Therapies in Spain
15.7. United Kingdom Market Size
- 15.7.1. Eczema Total Market Size in the United Kingdom
- 15.7.2. Eczema Market Size by Therapies in the United Kingdom
15.8. Japan Market Outlook
- 15.8.1. Japan Market Size
- 15.8.2. Eczema Total Market Size in Japan
- 15.8.3. Eczema Market Size by Therapies in Japan

한글목차

목차

제1장 주요 인사이트

제2장 습진 주요 요약

제3장 습진 경쟁 정보 분석

제4장 습진 : 시장 개요

제5장 습진 : 질환 배경과 개요

제6장 환자 동향

제7장 습진 역학과 환자 인구

제8장 치료 알고리즘, 현재 치료, 의료 행위

제9장 미충족 요구

제10장 습진 치료의 주요 평가항목

제11장 출시 제품

제12장 새로운 치료법

제13장 습진 : 주요 7개국 시장 분석

제14장 속성 분석

제15장 주요 7개국 : 시장 전망

제16장 습진 접금 및 상환 개요

제17장 KOL(Key Opinion Leader)의 견해

제18장 시장 성장 촉진요인

제19장 시장 장벽

제20장 부록

제21장 DelveInsight의 서비스 내용

제22장 면책사항

제23장 DelveInsight에 대해